XAIR
Beyond Air, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website beyondair.net
- Employees(FY) 98
- ISIN US08862L1035
Performance
+15.13%
1W
+3.01%
1M
-29.38%
3M
-13.02%
6M
-30.1%
YTD
-75.62%
1Y
Profile
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Technical Analysis of XAIR 2024-05-10
Overview:
In analyzing the technical indicators for XAIR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and recommendations for potential future price action.
...Recent News & Updates
- 2024-04-30 19:00
- 2024-03-21 00:00
- 2024-03-19 21:00
- 2024-02-12 19:51
- 2024-02-12 03:05
- 2024-01-17 19:00
- 2023-12-26 18:30
- 2023-12-20 12:40
- 2023-11-15 03:05
- 2023-11-13 21:00
- 2023-11-13 03:05
- 2023-11-03 00:00
- 2023-10-19 04:05
- 2023-10-17 04:05
- 2023-10-16 19:30
- 2023-10-15 19:30
- 2023-10-15 19:00
- 2023-10-03 19:30
- 2023-10-02 04:05
- 2023-09-26 21:00
- 2023-09-18 04:05
- 2023-09-06 19:30
- 2023-09-05 19:00
- 2023-08-10 04:05
- 2023-08-07 21:55
- 2023-08-07 04:05
- 2023-08-01 04:05
- 2023-07-27 22:13
- 2023-07-24 04:05
- 2023-06-22 04:05
Page 1 of 4
previousnext